パルミチン酸イソプロピルとは

パルミチン酸イソプロピルは、化粧品やスキンケア製品に広く使われる成分の一つであり、保湿効果や皮膚になじみやすいテクスチャーの実現に貢献します。しかし、過剰な使用による肌刺激やアレルギー症状の発現などのリスクもあるため、正しい使い方について注意が必要です。

1. 保湿効果

パルミチン酸イソプロピルは、皮膚の表面に膜を形成することで、水分蒸発を防ぐ保湿効果があります。皮膚は、乾燥するとバリア機能が低下し、外部からの刺激や菌などに対して防御力が弱くなってしまいます。そのため、パルミチン酸イソプロピルは、乾燥肌や敏感肌の人に向けて、保湿剤として使われることがあります。

1. テクスチャーの改善

パルミチン酸イソプロピルは、油性成分に属するため、水性成分と混ぜることで、乳化剤や乳液、クリームなどのスキンケア製品に使用されます。また、パルミチン酸イソプロピルは、皮膚になじみやすく、ベタつかないテクスチャーを実現するためにも用いられます。

パルミチン酸イソプロピルの配合目的

• エモリエント作用
• 感触改良
• 溶剤
• 毛髪の対してのツヤ感付与

パルミチン酸イソプロピルの安全性情報

パルミチン酸イソプロピルは、一部の人にとっては肌刺激性があるため、使用前にパッチテストを行うことが推奨されています。また、過剰な使用により、肌が乾燥したり、かぶれたり、かゆみが生じたりする場合があるため、使用量や使用頻度にも注意が必要です。さらに、パルミチン酸イソプロピルは、皮膚から吸収される可能性があるため、長期的な使用による副作用についても研究が進められています。一部の人にはアレルギー反応を引き起こす可能性があるため、初めて使用する場合は注意深く観察することが必要です。

・https://online.personalcarecouncil.org/ctfa-static/online/lists/cir-pdfs/PRS623.pdf

・https://online.personalcarecouncil.org/ctfa-static/online/lists/cir-pdfs/PRNS475.pdf

・https://online.personalcarecouncil.org/ctfa-static/online/lists/cir-pdfs/pr238.pdf

なし

Effects of isopropyl palmitate on the skin permeation of drugs.

Guo H, Liu Z, Li J, Nie S, Pan W.Biol Pharm Bull. 2006 Nov;29(11):2324-6. doi: 10.1248/bpb.29.2324.PMID: 17077540 Free article.

Investigation of Effect of Isopropyl Palmitate on Drug Release from Transdermal Patch and Molecular Dynamics Study.

Ruan J, Wan X, Quan P, Liu C, Fang L.AAPS PharmSciTech. 2019 Apr 25;20(5):174. doi: 10.1208/s12249-019-1370-7.PMID: 31028490

Microemulsions as transdermal drug delivery vehicles.

Kogan A, Garti N.Adv Colloid Interface Sci. 2006 Nov 16;123-126:369-85. doi: 10.1016/j.cis.2006.05.014. Epub 2006 Jul 14.PMID: 16843424 Review.

Microemulsions as a surrogate carrier for dermal drug delivery.

Azeem A, Khan ZI, Aqil M, Ahmad FJ, Khar RK, Talegaonkar S.Drug Dev Ind Pharm. 2009 May;35(5):525-47. doi: 10.1080/03639040802448646.PMID: 19016057 Review.

Evaluation of nicotinamide microemulsion on the skin penetration enhancement.

Boonme P, Boonthongchuay C, Wongpoowarak W, Amnuaikit T.Pharm Dev Technol. 2016;21(1):116-20. doi: 10.3109/10837450.2014.971378. Epub 2014 Oct 16.PMID: 25318786

Comparative evaluation of skin moisture after topical application of 10% and 30% lactobionic acid.

Algiert-Zielińska B, Mucha P, Rotsztejn H.J Cosmet Dermatol. 2018 Dec;17(6):1096-1100. doi: 10.1111/jocd.12485. Epub 2018 Jan 9.PMID: 29318715

Is Vitamin D(3) Transdermal Formulation Feasible? An Ex Vivo Skin Retention and Permeation.

D'Angelo Costa GM, Sales de Oliveira Pinto CA, Rodrigues Leite-Silva V, Rolim Baby A, Robles Velasco MV.AAPS PharmSciTech. 2018 Jul;19(5):2418-2425. doi: 10.1208/s12249-018-1065-5. Epub 2018 Jun 4.PMID: 29869312

Pomegranate Seed Oil Enhances the Percutaneous Absorption of trans-Resveratrol.

Liu W, Zhao Q, Lv L, Yan S, Song Q, Chen T, Yao Q.J Oleo Sci. 2018 Apr 1;67(4):479-487. doi: 10.5650/jos.ess17144. Epub 2018 Mar 9.PMID: 29526870 Free article.

Permeation study through bacterial cellulose membrane.

Wu C, Murtaza G, Yameen MA, Aamir MN, Akhtar M, Zhao Y.Acta Pol Pharm. 2014 Mar-Apr;71(2):297-300.PMID: 25272650

A Quasi-experimental Study to Explore the Effect of Barrier Cream on the Peristomal Skin of Patients With a Tracheostomy.

Karaca T, Korkmaz F.Ostomy Wound Manage. 2018 Mar;64(3):32-39.PMID: 29584610

Dermal peptide delivery using enhancer molecules and colloidal carrier systems. Part III: Tetrapeptide GEKG.

Sommer E, Neubert RHH, Mentel M, Tuchscherer B, Mrestani Y, Wohlrab J.Eur J Pharm Sci. 2018 Nov 1;124:137-144. doi: 10.1016/j.ejps.2018.08.034. Epub 2018 Aug 27.PMID: 30165235

Eye and skin irritation tests on the rabbit of several fatty acid esters.

Guillot JP, Giauffret JY, Martini MC, Gonnet JF, Soulé G.Int J Cosmet Sci. 1979 Oct;1(5):265-90. doi: 10.1111/j.1467-2494.1979.tb00222.x.PMID: 19467074

Comedogenicity in rabbit: some cosmetic ingredients/vehicles.

Nguyen SH, Dang TP, Maibach HI.Cutan Ocul Toxicol. 2007;26(4):287-92. doi: 10.1080/15569520701555383.PMID: 18058303

Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives.

Trimble JO, Light B.Int J Pharm Compd. 2017 Nov-Dec;21(6):530-535.PMID: 29220342

Effect of penetration enhancers on skin permeation of trazodone hydrochloride from matrix type transdermal formulation through mouse and human cadaver epidermis.

Das MK, Bhattacharya A, Ghosal SK.Acta Pol Pharm. 2006 Nov-Dec;63(6):535-41.PMID: 17438871

Effect of (E)-2-isopropyl-5-methylcyclohexyl octadec-9-enoate on transdermal delivery of Aconitum alkaloids.

Zhao L, Fang L, Li Y, Zheng N, Xu Y, Wang J, He Z.Drug Dev Ind Pharm. 2011 Mar;37(3):290-9. doi: 10.3109/03639045.2010.510141. Epub 2010 Nov 7.PMID: 21054218

Topical delivery of flurbiprofen from pluronic lecithin organogel.

Pandey MS, Belgamwar VS, Surana SJ.Indian J Pharm Sci. 2009 Jan;71(1):87-90. doi: 10.4103/0250-474X.51955.PMID: 20177469 Free PMC article.

Microemulsion-loaded hydrogel formulation of butenafine hydrochloride for improved topical delivery.

Pillai AB, Nair JV, Gupta NK, Gupta S.Arch Dermatol Res. 2015 Sep;307(7):625-33. doi: 10.1007/s00403-015-1573-z. Epub 2015 May 26.PMID: 26006164

Propolis organogel as a novel topical delivery system for treating wounds.

Balata G, El Nahas HM, Radwan S.Drug Deliv. 2014 Feb;21(1):55-61. doi: 10.3109/10717544.2013.847032. Epub 2013 Dec 3.PMID: 24295500

Enhancement of the skin permeation of clindamycin phosphate by Aerosol OT/1-butanol microemulsions.

Junyaprasert VB, Boonsaner P, Leatwimonlak S, Boonme P.Drug Dev Ind Pharm. 2007 Aug;33(8):874-80. doi: 10.1080/03639040600975097.PMID: 17729105

Development, characterization, molecular docking, and in vivo skin penetration of coenzyme Q10 nanostructured lipid carriers using tristearin and stearyl alcohol for dermal delivery.

Aryani NLD, Siswodihardjo S, Soeratri W, Sari NFI.J Basic Clin Physiol Pharmacol. 2021 Jun 25;32(4):517-525. doi: 10.1515/jbcpp-2020-0512.PMID: 34214318

Pluronic lecithin organogel as a topical drug delivery system.

Pandey M, Belgamwar V, Gattani S, Surana S, Tekade A.Drug Deliv. 2010 Jan;17(1):38-47. doi: 10.3109/10717540903508961.PMID: 22747074

The hairless guinea-pig as a model for treatment of cumulative irritation in humans.

Andersen F, Hedegaard K, Petersen TK, Bindslev-Jensen C, Fullerton A, Andersen KE.Skin Res Technol. 2006 Feb;12(1):60-7. doi: 10.1111/j.0909-725X.2006.00133.x.PMID: 16420540 Clinical Trial.

Effect of hydrophobic permeation enhancers on the release and skin permeation kinetics from matrix type transdermal drug delivery system of ketotifen fumarate.

Bhattacharya A, Ghosal SK.Acta Pol Pharm. 2001 Mar-Apr;58(2):101-5.PMID: 11501785

Preparation and evaluation of diltiazem hydrochloride diffusion-controlled transdermal delivery system.

Limpongsa E, Umprayn K.AAPS PharmSciTech. 2008;9(2):464-70. doi: 10.1208/s12249-008-9062-8. Epub 2008 Mar 14.PMID: 18431661 Free PMC article.

Evaluation of the percutaneous absorption of chlorpromazine from PLO gels across porcine ear and human abdominal skin.

Alsaab H, Alzhrani RM, Boddu SH.Drug Dev Ind Pharm. 2016 Aug;42(8):1258-66. doi: 10.3109/03639045.2015.1122610. Epub 2015 Dec 21.PMID: 26599694

Preparation and in vitro evaluation of a pluronic lecithin organogel containing ricinoleic acid for transdermal delivery.

Boddu SH, Bonam SP, Wei Y, Alexander K.Int J Pharm Compd. 2014 May-Jun;18(3):256-61.PMID: 25306775

Skin healing preparations: compared in vitro diffusion of the active ingredients.

Vennat B, Arvouet-Grand A, Pourrat A.Drug Dev Ind Pharm. 1998 Mar;24(3):253-60. doi: 10.3109/03639049809085617.PMID: 9876582

Transdermal delivery of hydrophobic and hydrophilic local anesthetics from o/w and w/o Brij 97-based microemulsions.

Junyaprasert VB, Boonme P, Songkro S, Krauel K, Rades T.J Pharm Pharm Sci. 2007;10(3):288-98.PMID: 17727792

Lecithin organogel as matrix for transdermal transport of drugs.

Willimann H, Walde P, Luisi PL, Gazzaniga A, Stroppolo F.J Pharm Sci. 1992 Sep;81(9):871-4. doi: 10.1002/jps.2600810906.PMID: 1432631